Peretz T - Search Results

1

Mutation spectrum in HNPCC in the Israeli population.

Goldberg Y, Porat RM, Kedar I, Shochat C, Sagi M, Eilat A, Mendelson S, Hamburger T, Nissan A, Hubert A, Kadouri L, Pikarski E, Lerer I, Abeliovich D, Bercovich D, Peretz T. Goldberg Y, et al. Among authors: peretz t. Fam Cancer. 2008;7(4):309-17. doi: 10.1007/s10689-008-9191-y. Epub 2008 Apr 4. Fam Cancer. 2008. PMID: 18389388

2

The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals.

Struewing JP, Abeliovich D, Peretz T, Avishai N, Kaback MM, Collins FS, Brody LC. Struewing JP, et al. Among authors: peretz t. Nat Genet. 1995 Oct;11(2):198-200. doi: 10.1038/ng1095-198. Nat Genet. 1995. PMID: 7550349

3

[Genetic counseling for families at high cancer risk].

Sagi M, Heching N, Kadouri L, Abeliovich D, Zlotogora J, Bach G, Peretz T. Sagi M, et al. Among authors: peretz t. Harefuah. 1996 Apr 1;130(7):441-6, 504. Harefuah. 1996. PMID: 8707209 Hebrew.

4

Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype.

Ben-Yehuda D, Krichevsky S, Caspi O, Rund D, Polliack A, Abeliovich D, Zelig O, Yahalom V, Paltiel O, Or R, Peretz T, Ben-Neriah S, Yehuda O, Rachmilewitz EA. Ben-Yehuda D, et al. Among authors: peretz t. Blood. 1996 Dec 1;88(11):4296-303. Blood. 1996. PMID: 8943866 Free article.

5

The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women.

Abeliovich D, Kaduri L, Lerer I, Weinberg N, Amir G, Sagi M, Zlotogora J, Heching N, Peretz T. Abeliovich D, et al. Among authors: peretz t. Am J Hum Genet. 1997 Mar;60(3):505-14. Am J Hum Genet. 1997. PMID: 9042909 Free PMC article.

6

Cisplatin-induced non-convulsive encephalopathy.

Lyass O, Lossos A, Hubert A, Gips M, Peretz T. Lyass O, et al. Among authors: peretz t. Anticancer Drugs. 1998 Jan;9(1):100-4. doi: 10.1097/00001813-199801000-00013. Anticancer Drugs. 1998. PMID: 9491799

7

The 8765delAG mutation in BRCA2 is common among Jews of Yemenite extraction.

Lerer I, Wang T, Peretz T, Sagi M, Kaduri L, Orr-Urtreger A, Stadler J, Gutman H, Abeliovich D. Lerer I, et al. Among authors: peretz t. Am J Hum Genet. 1998 Jul;63(1):272-4. doi: 10.1086/301924. Am J Hum Genet. 1998. PMID: 9634522 Free PMC article. No abstract available.

8

Genetic testing of breast and ovarian cancer patients: clinical characteristics and hormonal risk modifiers.

Kaduri L, Gibs M, Hubert A, Sagi M, Heching N, Lerer I, Uziely B, Weinberg N, Abeliovich D, Peretz T. Kaduri L, et al. Among authors: peretz t. Eur J Obstet Gynecol Reprod Biol. 1999 Jul;85(1):75-80. doi: 10.1016/s0301-2115(98)00286-3. Eur J Obstet Gynecol Reprod Biol. 1999. PMID: 10428326

9

The Jewish Ashkenazi founder mutations in the BRCA1/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer.

Hubert A, Peretz T, Manor O, Kaduri L, Wienberg N, Lerer I, Sagi M, Abeliovich D. Hubert A, et al. Among authors: peretz t. Am J Hum Genet. 1999 Sep;65(3):921-4. doi: 10.1086/302525. Am J Hum Genet. 1999. PMID: 10441598 Free PMC article. No abstract available.

10

[Brief preoperative radiotherapy reduces local recurrences and improves survival in rectal cancer].

Peretz T, Weshler Z, Goldberg Y, Durst AL, Freund HR. Peretz T, et al. Harefuah. 2000 Jan 16;138(2):96-9, 175. Harefuah. 2000. PMID: 10883067 Hebrew.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

325 results

Search Page